SPENDING by pharma companies promoting their medicines in the USA rose by more than 60% over the last two decades according to a study reported by Scimex.
Marketing of drugs, disease awareness campaigns, health services and laboratory testing increased to $29.9 billion in 2016 from $17.7 billion in 1997.
The data showed that while most of the advertising was angled at health professionals, direct-to-consumer advertising grew to $9.6 billion, representing about one third of the investment.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jan 19
